CMP-3013

N/A

Report date: 2024/11/12 10:42:47
NME

Base Information

Drug NameCMP-3013
Drug Alias NameCMP3013CMP-3013
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMitochondrial proteins modulators
TargetsMitochondrial proteins
Therapy Area/IndicationsAutism Spectrum DisorderMitochondrial DiseasesBarth Syndrome +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National UniversityCAMP Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCAMP Therapeutics Co LtdSeoul National University
Inactive CompaniesN/A
Active IndicationsAutism Spectrum DisorderMitochondrial DiseasesBarth Syndrome +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A